Randolph Bancorp, Inc. Announces Fourth Quarter and Year End 2017 Financial Results
Feb 28, 2018 01:16 am UTC| Business
STOUGHTON, Mass., Feb. 27, 2018 -- Randolph Bancorp, Inc. (the “Company”) (NASDAQ:RNDB), the holding company for Randolph Savings Bank (the “Bank”), today announced a net loss of $1.6 million, or $0.28 per share, for...
NMI Holdings, Inc. Announces Pricing of Public Offering of Common Stock
Feb 28, 2018 01:14 am UTC| Business
EMERYVILLE, Calif., Feb. 27, 2018 -- NMI Holdings, Inc. (Nasdaq:NMIH) (the “Company”) today announced the pricing of its previously announced underwritten registered public offering of 3,700,000 shares of its Class A...
Cohesity Builds on Momentum in Australia and New Zealand With New Partnerships and Managing Director
Feb 28, 2018 01:00 am UTC| Business
SAN JOSE, Calif., Feb. 27, 2018 -- Cohesity, the leader of hyperconverged secondary storage, announced today that the company has further expanded its presence in the Asia Pacific market, bringing on Theo Hourmouzis as...
Eastern, western aesthetics converge Taiwan Lantern Festival in Chiayi
Feb 28, 2018 00:42 am UTC| Business
Taipei, Taiwan, Feb. 28, 2018 -- Visitors to the 2018 Taiwan Lantern Festival hosted by the Chiayi County government were surprised to find that they could feast eyes on the aesthetics of not only Asian relics but also...
Sensa Clinical Launches Under New Ownership With Clinically Validated Ingredients
Feb 28, 2018 00:40 am UTC| Business
New Formula Blocks up to 350 Calories Per Day‡ and Inhibits Hunger Hormone Ghrelin SALT LAKE CITY, Feb. 27, 2018 -- One of the most successful brands in the history of weight-loss supplements, Sensa, is making a...
Maiden Holdings, Ltd. Announces Fourth Quarter and Full Year 2017 Financial Results
Feb 28, 2018 00:36 am UTC| Business
Highlights for the Fourth Quarter and Full Year Ended December 31, 2017 Fourth quarter of 2017 net loss attributable to Maiden common shareholders of $133.6 million, or $1.59 per diluted common share compared with a net...
Feb 28, 2018 00:31 am UTC| Business
TOKYO, Feb. 28, 2018 -- AnGes, Inc., a biopharmaceutical company focused on developing innovative gene-based medicines for serious diseases, announced today the treatment of the first patient with NF-kappa B decoy oligo...